Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?

Background: Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is characterized by inflammatory lung injury, progressive parenchymal stiffening and consolidation, alveolar and airway collapse, altered vascular permeability, diffuse alveolar damage, and surfactant deficiency. COVID-19 cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruaro, Barbara, Confalonieri, Paola, Pozzan, Riccardo, Tavano, Stefano, Mondini, Lucrezia, Baratella, Elisa, Pagnin, Alessandra, Lerda, Selene, Geri, Pietro, Biolo, Marco, Confalonieri, Marco, Salton, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267619/
https://www.ncbi.nlm.nih.gov/pubmed/35806862
http://dx.doi.org/10.3390/jcm11133577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267619/
https://www.ncbi.nlm.nih.gov/pubmed/35806862
http://dx.doi.org/10.3390/jcm11133577

Ejemplares similares